BC Legislature - Health Committee, 40th Parliament

Darcy, Judy (New Westminster)

As subject

election as Deputy Chair of Health Committee 1:1105 (Letnick) 1:1105

experience in health sector and as MLA 1:1130

B.C., rural B.C.

health care services, emergency services and paramedic services 4:1005

Canadian Institute for Health Information

report on health care system benchmarking 2:1435

tracking and reporting of progress on health care system priorities 3:1200

Cancer

chemotherapy drugs, coverage under PharmaCare program 4:1150-1155

Denmark

long-term care system 3:1035

Drugs, prescription drugs

prescribers, education and information, academic and industry detailing 3:1320

prices and cost management, comparisons among jurisdictions 3:1320

Goldsmith, Laurie, research and report on community health centres 3:1200

Health

health status and outcomes in Canada and other countries 2:1425

health status and outcomes, measurement 3:1200

Health Committee

election of Chair and Deputy Chair 1:1105

membership and experience 1:1130

research by staff and briefing note 2:1340

terms of reference 1:1110

witnesses, invitation 2:1325

work of committee 3:1535

Health, continuing and long-term care

system, integrated system 3:1035

Health, health authorities

attendance and presentations at Health Committee meetings 2:1325

Health, health care facilities and hospitals

community health centres 3:1145, 3:1200

Health, health care funding

funding for community health centres 3:1145

funding for nurse practitioners 3:1145

performance-based funding 3:1450

ratio to GDP 2:1410

Health, health care system

comparisons among jurisdictions

coverage of health care system components 3:1010

studies 2:1415-1420, 2:1430, 2:1450

costs and spending

public and private spending 2:1445

role of preventive care 3:1200

emergency services, use for primary care 3:1450

primary health care

interdisciplinary teams 3:1035

reforms, strategies 3:1535

surgical services, non-priority areas 3:1200

sustainability and outcomes 1:1110

system complexity and interdependencies 3:1530-1535

system design and analysis 1:1115

wait-lists and waiting times

surgery wait-lists 3:1450

Health, public health

healthy lifestyle, factors 2:1340

preventive health care 3:1535-1540

Nurses

nurse practitioners, supply 4:1005

PharmaCare program

reform 3:1320

Physicians

family physicians, divisions of family practice, inclusion of nurse practitioners 4:1005

payment models, interjurisdictional comparisons 2:1450

prescription of drugs, telephone prescription 4:1150

Davidson, Heather

Presentation to committee on behalf of Health Ministry 4:0905-1030

B.C. Dental Association

recommendations to government 4:1020

B.C., rural B.C.

health care services 4:0955-1000

health care services, emergency services and paramedic services 4:1010

physician supply, recruitment programs 4:0955-1000

Canada Health Act (federal)

purpose 4:0920-0925

Canadian Institute for Health Information

role 4:0925

Disease

chronic disease, incidence 4:0930

chronic disease, prevention 4:0940

Finegood, Diane, comments on services for seniors 4:1010

First Nations Health Authority

role and responsibilities 4:0915

Health

health status and outcomes

health status and outcomes in B.C. 4:0945

measurement 4:0925, 4:0950

Health Authorities Act

purpose 4:0925

Health, health authorities

collaborative services committees, role 4:0950, 4:1000-1005

establishment 4:0925

role and responsibilities 4:0915

Health, health care facilities and hospitals

infrastructure, replacement of aging infrastructure 4:0940, 4:1010

private hospitals, licensing and regulation 4:0925

Health, health care funding

activity-based funding 4:0930, 4:0945

funding for health authorities, community-based services 4:1005

increases 4:0935-0940

transfer payments from federal government

conditions for funding 4:0920-0925

Health, health care system

accessibility

accessibility 4:0925

challenges 4:0925-0940

chronic disease management 4:0930

community-based care

treatment of ambulatory care sensitive conditions 4:0950

costs and spending

comparisons among jurisdictions 4:0925

costs and cost-savings related to age groups 4:1020-1025

costs and spending 4:0940

individual use of services 4:0935-0940

management 4:0935

emergency services

management 4:0945

health professionals

emergency medical assistants, regulation 4:0920

regulation 4:0920

role 4:0915-0920

impact of demographic trends and sustainability 4:0905-0910

legislation 4:0920-0930

medical imaging services 4:0945

patients

feedback on system, Patient Voices Network 4:0950

shared care plans 4:0950

personal health information, electronic health records 4:0930

primary health care

improvements 4:0930, 4:0940

integrated primary care and community-based care 4:0940, 4:0950, 4:1005, 4:1015

services 4:0910-0915

quality of care

quality 4:0925

reforms

barriers to change 4:1025-1030

innovation and change agenda 4:0940-0945, 4:1000

Lean process 4:0945, 4:1000

levers and tools 4:0915

shared purchasing 4:0945

strategies 4:0930-1000

regionalization, role of regional boards 4:0925

secondary health care

services 4:0915

service delivery

service delivery 4:0920

service delivery in hospitals 4:0945

service providers 4:0915

services

categorization 4:0910-0915

increase in usage 4:0940

services for First Nations people 4:0915

services for seniors

care standards in hospitals, 48/6 care protocol 4:0945, 4:1015

comparison among jurisdictions, international expert session 4:1010

seniors with chronic illness 4:0935-0940

service delivery 4:0930

system

complexity and interdependencies 4:0905-0910, 4:1025

effectiveness, productivity and sustainability 4:0945, 4:1000

overview 4:0905-1000

population segmentation based on health care needs 4:0910, 4:0935-0940

public health insurance model 4:0905

standards 4:0925

technology

changes 4:0930

information technology management 4:0945

telehealth, expansion 4:0955, 4:1015-1020

tertiary health care

services 4:0915

travel for treatment and diagnostic services, travel support programs 4:1000

wait-lists and waiting times

comparisons among jurisdictions 4:0930

surgery wait-lists 4:0945

Health Ministry

role and responsibilities 4:0915

Health Professions Act

purpose 4:0920

Health, public health

health promotion and disease prevention, results 4:0940-0945

healthy families B.C. strategy 4:0945

Home care and home support services

Better at Home program 4:0955

expansion of services 4:0955, 4:1005

Home is Best program 4:1005

Hospitals Act

purpose 4:0925

Johns Hopkins Hospital

administrative data model for health care services 4:0910

Kamloops

mental health services, access to primary care 4:1005, 4:1015

Medical Services Commission

role and responsibilities 4:0920-0925

Medical Services Plan

plan 4:0910

Medicare Protection Act

purpose 4:0920-0925

Mental health

mental health plan 4:0950

mental illness and addiction, treatment services 4:0935, 4:0950-0955

programs and services, access to primary care 4:1005, 4:1015

Nurses

nurse practitioners, supply 4:0950, 4:1005

Physicians

family physicians

divisions of family practice, establishment 4:0950

divisions of family practice, inclusion of nurse practitioners 4:1005

payment models

fee-for-service payment system 4:0920

supply

GP for Me program 4:1000

number 4:0915

training

training for medical students from rural communities 4:0955

Provincial Health Services Authority

role and responsibilities 4:0915

Seniors

abuse, prevention 4:0955

advocate, recruitment 4:0955

housing, options 4:0955

Denmark

Long-term care system (Darcy) 3:1035

Dental care

Public and private spending (Morgan, S.) 3:0920, 3:0940, 3:1015

Depression era See United States
Detailing See Prescribers, education and information under Drugs – Prescription drugs
Di Matteo, Livio and Rosanna Di Matteo

Study on health care costs (Anis, A.) 3:1440

Diabetes

Causes and incidence (Anis, A.) 3:1355

Diagnostic services See Health – Health care system
Disease See particular conditions, diseases, etc.

Chronic disease

incidence (Davidson, H.) 4:0930

management See Chronic disease management under Health – Health care system

prevention (Davidson, H.) 4:0940

Diseases, prescription drug treatment and coverage (Walman, B.) 4:1040, 4:1055-1100, 4:1120, 4:1135

Prevalence of specific diseases See Morbidity under Health

Disneyland

Guest flow models in parks (Anis, A.) 3:1430

Divisions of family practice See Family physicians under Physicians
Doctors See Physicians
Douglas, Tommy

Work on health care system (Morgan, S.) 3:0930-0935

Drug Benefit Council

Role in drug review process (Walman, B.) 4:1045-1055

Drugs – Prescription drugs

Accessibility and affordability

access for persons with high care needs or need for high-cost drugs (Morgan, S.) 3:1300

impact on health status and outcomes (Morgan, S.) 3:1255, 3:1310-1315, 3:1335

B.C. PharmaCare program See PharmaCare program

Costs and spending See also Prices and cost management below under this main heading

impact of demographic trends (Morgan, S.) 3:1300-1305

public and private spending (Morgan, S.) 3:0920, 3:0940, 3:0955, 3:1005, 3:1300-1305 (Walman, B.) 4:1100-1105

public opinion and research (Walman, B.) 4:1155

role of prescribing and usage patterns (Morgan, S.) 3:1305

Coverage See also Coverage under PharmaCare program; particular diseases, drugs, population groups, etc.

Coverage models

age-based model (Morgan, S.) 3:1305

catastrophic coverage model See coverage for particular income thresholds under this subheading

compulsory insurance model (Morgan, S.) 3:1255, 3:1305

coverage for drugs of known benefit (Morgan, S.) 3:1310, 3:1320

coverage for particular income thresholds (Morgan, S.) 3:1250-1300

coverage for particular social groups (Morgan, S.) 3:1250

Coverage programs

comparisons among jurisdictions See also particular jurisdictions

(Barnett) 3:1315 (Morgan, S.) 3:1250-1305, 3:1315, 3:1330-1335

employer programs See also Health benefits and prescription drug coverage under Pensions

(Morgan, S.) 3:1255

formularies of eligible drugs (Lee) 3:1335 (Morgan, S.) 3:1325-1335

governance (Morgan, S.) 3:1335

issues (Morgan, S.) 3:1305-1310

Deductibles and private insurance costs (Morgan, S.) 3:1250-1305

Detailing See Prescribers, education and information below under this main heading

Dispensing of drugs See also Pharmacists

role of pharmacists and physicians (Morgan, S.) 3:1320

Drug review process See Review process below under this main heading; Drug approval process under PharmaCare program

Electronic prescription and drug information systems (Morgan, S.) 3:1315, 3:1325

Formularies of drugs covered under health benefit programs See Coverage programs, formularies above under this main heading

Fraud prevention (Hammell) 4:1150 (Walman, B.) 4:1150

Funding See Funding for drugs under Health – Health care funding

Generic drugs See Prices and cost management below under this main heading

Low-cost alternative drug program See Low-cost alternative drug program under PharmaCare program

PharmaCare program See PharmaCare program

Pharmacists See Pharmacists

Prescribers See also Prescription of drugs under Physicians

education and information (Morgan, S.) 3:1315-1320

education and information, academic and industry detailing (Darcy) 3:1320 (Morgan, S.) 3:1320-1325

education and information, academic detailing program (Walman, B.) 4:1100

Price regulation (Moneo, M.) 4:1130

Prices and cost management

"biologic" drugs (Morgan, S.) 3:1330

comparisons among jurisdictions See also particular jurisdictions

(Darcy) 3:1320 (Larson) 3:1015 (Lee) 3:1320, 3:1335 (Morgan, S.) 3:1315-1320, 3:1335

comparisons among jurisdictions, studies (Morgan, S.) 3:1315-1320

generic drugs (Lee) 3:1335 (Moneo, M.) 4:1130 (Morgan, S.) 3:1305-1320, 3:1330-1335

high-cost and specialty drugs (Bing) 3:1330 (Letnick) 4:1155 (Moneo, M.) 4:1130 (Morgan, S.) 3:1305-1310 (Walman, B.) 4:1140, 4:1155-1200

national purchasing alliance (Walman, B.) 4:1045-1050, 4:1200

national purchasing strategy proposal (Morgan, S.) 3:1310-1315

patented drugs (Morgan, S.) 3:1330

potential impact of European trade agreement See Canada–European Union Comprehensive Economic and Trade Agreement

prices and cost management (Moneo, M.) 4:1130-1135 (Walman, B.) 4:1140

purchasing contracts with drug manufacturers (Morgan, S.) 3:1305-1320

Public education and information (Walman, B.) 4:1045-1055

Reference-based pricing See Reference drug program under PharmaCare program

Research and development, investment (Lee) 3:1335 (Morgan, S.) 3:1335

Review process See also Drug approval process under PharmaCare program

(Letnick) 3:1335 (Morgan, S.) 3:1335

Review process, common drug review (Walman, B.) 4:1040-1055, 4:1155

Review process, national process See common drug review above under this subheading

Safety See Review process below under this main heading

Drummond, Don

Comments on health care system (Morgan, S.) 3:1005

DTES See Downtown Eastside under Vancouver, B.C.